These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 32778338)

  • 1. Meta-analysis of Left Atrial Appendage Closure Versus Anticoagulation in Patients With Atrial Fibrillation.
    Kheiri B; Kumar K; Simpson TF; Osman M; Dalouk K; Beitinjaneh B; Golwala H; Henrikson CA
    Am J Cardiol; 2020 Oct; 132():181-182. PubMed ID: 32778338
    [No Abstract]   [Full Text] [Related]  

  • 2. Left atrial appendage closure: An emerging option in atrial fibrillation when oral anticoagulants are not tolerated.
    Peritz DC; Chung EH
    Cleve Clin J Med; 2015 Mar; 82(3):167-76. PubMed ID: 25932742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The left atrial appendage: An enigmatic friend or foe and implications of closure.
    Benson JM; Keesee J; Smith L; Navarro J; Khouzam RN
    Curr Probl Cardiol; 2024 Aug; 49(8):102620. PubMed ID: 38718930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left Atrial Appendage Closure Versus Oral Anticoagulants in Atrial Fibrillation: A Meta-Analysis of Randomized Trials.
    Turagam MK; Osmancik P; Neuzil P; Dukkipati SR; Reddy VY
    J Am Coll Cardiol; 2020 Dec; 76(23):2795-2797. PubMed ID: 33272374
    [No Abstract]   [Full Text] [Related]  

  • 5. Left atrial appendage closure devices: A reasonable therapeutic alternative.
    Reddy VY
    Heart Rhythm; 2018 Feb; 15(2):302-305. PubMed ID: 29030234
    [No Abstract]   [Full Text] [Related]  

  • 6. Left atrial appendage closure.
    Lin AC; Knight BP
    Prog Cardiovasc Dis; 2015; 58(2):195-201. PubMed ID: 26241302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous left atrial appendage closure therapy for the prevention of stroke.
    Blue Cross Blue Shield Asssociation
    Technol Eval Cent Assess Program Exec Summ; 2014 Oct; 29(5):1-4. PubMed ID: 25577826
    [No Abstract]   [Full Text] [Related]  

  • 8. [Percutaneous left atrial appendage closure for stroke prevention in atrial fibrillation: is left atrial appendage closure an alternative for anticoagulation?].
    Boersma LVA; Rensing BJWM; Wintgens LI; Klaver M; Swaans MJ
    Ned Tijdschr Geneeskd; 2018 Jun; 162():. PubMed ID: 30040296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial fibrillation and stroke: risk factors, anticoagulation, and left atrial appendage occluders.
    Lüscher TF
    Eur Heart J; 2016 Aug; 37(31):2443-5. PubMed ID: 27558318
    [No Abstract]   [Full Text] [Related]  

  • 10. Left Atrial Appendage Management: No Better Time Than the Present.
    Romano MA; Bergquist CS
    Innovations (Phila); 2019; 14(6):498-502. PubMed ID: 31840574
    [No Abstract]   [Full Text] [Related]  

  • 11. Closure of Left Atrial Appendage to Prevent Stroke: Devices and Status.
    Safavi-Naeini P; Rasekh A
    Tex Heart Inst J; 2018 Jun; 45(3):172-174. PubMed ID: 30072856
    [No Abstract]   [Full Text] [Related]  

  • 12. Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation and contraindication for anticoagulation.
    Grosset-Janin D; Barth E; Bertrand B; Detante O
    Rev Neurol (Paris); 2015 May; 171(5):426-32. PubMed ID: 25912470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin.
    Reddy VY; Akehurst RL; Armstrong SO; Amorosi SL; Brereton N; Hertz DS; Holmes DR
    Europace; 2016 Jul; 18(7):979-86. PubMed ID: 26838691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous left atrial appendage closure is not ready for routine clinical use.
    Mandrola J; Foy A; Naccarelli G
    Heart Rhythm; 2018 Feb; 15(2):298-301. PubMed ID: 29030233
    [No Abstract]   [Full Text] [Related]  

  • 15. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
    Reddy VY; Doshi SK; Kar S; Gibson DN; Price MJ; Huber K; Horton RP; Buchbinder M; Neuzil P; Gordon NT; Holmes DR;
    J Am Coll Cardiol; 2017 Dec; 70(24):2964-2975. PubMed ID: 29103847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left Atrial Appendage Closure Device With Delivery System: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2017; 17(9):1-106. PubMed ID: 28744335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is percutaneous closure of the left atrial appendage comparable to anticoagulants for atrial fibrillation?
    Uslar T; Anabalón J
    Medwave; 2015 Aug; 15 Suppl 2():e6218. PubMed ID: 26335602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Left Atrial Appendage Revised.
    Evora PRB; Menardi AC; Celotto AC; Albuquerque AAS; Chagas HMA; Rodrigues AJ
    Braz J Cardiovasc Surg; 2017; 32(6):517-522. PubMed ID: 29267615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Outcomes Following Left Atrial Appendage Closure: Gaining Perspective on Non-pharmacological Stroke Prevention in Atrial Fibrillation.
    Asmarats L; Rodés-Cabau J
    Rev Esp Cardiol (Engl Ed); 2019 Jun; 72(6):440-442. PubMed ID: 30670356
    [No Abstract]   [Full Text] [Related]  

  • 20. Managing the Left Atrial Appendage in Atrial Fibrillation: Current State of the Art.
    Khawar W; Smith N; Masroor S
    Ann Thorac Surg; 2017 Dec; 104(6):2111-2119. PubMed ID: 28826990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.